US Physicalrapy Inc (USPH)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents US$ in thousands 41,362 116,959 112,911 132,290 152,825 147,685 160,738 32,605 31,594 37,914 48,572 24,229 28,567 19,188 20,419 17,937 32,918 30,129 43,555 89,551
Short-term investments US$ in thousands 2,979 2,663 3,500 3,500 2,614 2,858 1,948
Total current liabilities US$ in thousands 116,283 115,300 107,099 102,536 102,185 82,356 85,816 90,833 85,489 81,488 85,105 89,020 83,481 81,668 75,379 90,825 93,492 93,200 87,353 71,149
Cash ratio 0.36 1.01 1.05 1.32 1.52 1.84 1.91 0.39 0.40 0.49 0.57 0.27 0.34 0.23 0.27 0.20 0.35 0.32 0.50 1.26

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($41,362K + $—K) ÷ $116,283K
= 0.36

The cash ratio of US Physicalrapy Inc has fluctuated over the years based on the provided data. In March 2020, the cash ratio was 1.26, indicating that the company had $1.26 in cash and cash equivalents for every dollar of current liabilities.

Subsequently, there was a significant decrease in the cash ratio to 0.50 in June 2020, followed by further declines in September 2020 (0.32) and December 2020 (0.35). These lower ratios suggest a lower level of liquidity and potential difficulty in meeting short-term liabilities with available cash on hand.

In the following quarters, the cash ratio continued to fluctuate, with some slight improvements seen in March 2021 (0.20) and June 2021 (0.27). However, the ratio remained below 1, indicating a potential liquidity concern.

The trend changed starting from September 2021, with the cash ratio improving to 0.23 and further increasing in the subsequent periods, reaching a peak of 1.91 in June 2023. These higher ratios suggest that the company had significantly more cash and cash equivalents relative to its current liabilities during this period, signifying improved liquidity.

From December 2023 to December 2024, the cash ratio gradually decreased from 1.52 to 0.36. While the ratios remained above 1 for several quarters, indicating a comfortable level of liquidity, the decreasing trend towards the end of the period may raise concerns about the company's ability to cover short-term obligations with its existing cash holdings.

In conclusion, the analysis of US Physicalrapy Inc's cash ratio highlights fluctuations in liquidity over the analyzed period. It is essential for the company to maintain a balance between cash reserves and operational needs to ensure financial stability and meet short-term obligations effectively.


Peer comparison

Dec 31, 2024

Company name
Symbol
Cash ratio
US Physicalrapy Inc
USPH
0.36
Privia Health Group Inc
PRVA
1.01